Related Experiment Video

Updated: Jun 9, 2026

A Novel Microdissection Approach to Recovering Mycobacterium tuberculosis Specific Transcripts from Formalin Fixed Paraffin Embedded Lung Granulomas
07:42

A Novel Microdissection Approach to Recovering Mycobacterium tuberculosis Specific Transcripts from Formalin Fixed Paraffin Embedded Lung Granulomas

Published on: June 5, 2014

Editorial: Investigating lung biology, metabolism, and host susceptibility in mycobacterial infections

Pallavi Chandra1, Andrew T Roth2, Katharina Ronacher3,4

  • 1Division of Infectious Diseases, Department of Medicine, Washington University School of Medicine, St. Louis, MO, United States.

Frontiers in Cellular and Infection Microbiology
|June 8, 2026
PubMed
Abstract

No abstract available in PubMed .

Keywords:
Mycobacterium aviumgranulomahost susceptibilitylung biologymacrophagemycobacteriatuberculosis

More Related Videos

A 3D Human Lung Tissue Model for Functional Studies on Mycobacterium tuberculosis Infection
10:10

A 3D Human Lung Tissue Model for Functional Studies on Mycobacterium tuberculosis Infection

Published on: October 5, 2015

Sample Preparation of Mycobacterium tuberculosis Extracts for Nuclear Magnetic Resonance Metabolomic Studies
07:56

Sample Preparation of Mycobacterium tuberculosis Extracts for Nuclear Magnetic Resonance Metabolomic Studies

Published on: September 3, 2012

Related Experiment Videos

Last Updated: Jun 9, 2026

A Novel Microdissection Approach to Recovering Mycobacterium tuberculosis Specific Transcripts from Formalin Fixed Paraffin Embedded Lung Granulomas
07:42

A Novel Microdissection Approach to Recovering Mycobacterium tuberculosis Specific Transcripts from Formalin Fixed Paraffin Embedded Lung Granulomas

Published on: June 5, 2014

A 3D Human Lung Tissue Model for Functional Studies on Mycobacterium tuberculosis Infection
10:10

A 3D Human Lung Tissue Model for Functional Studies on Mycobacterium tuberculosis Infection

Published on: October 5, 2015

Sample Preparation of Mycobacterium tuberculosis Extracts for Nuclear Magnetic Resonance Metabolomic Studies
07:56

Sample Preparation of Mycobacterium tuberculosis Extracts for Nuclear Magnetic Resonance Metabolomic Studies

Published on: September 3, 2012

Related Concept Videos

Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Tuberculosis01:23

Tuberculosis

Tuberculosis (TB) remains a significant global health concern, primarily targeting the lungs and spreading through airborne transmission. Infection begins when aerosolized droplet nuclei, expelled by an individual with active TB, are inhaled by another person. These microscopic particles carry Mycobacterium tuberculosis, the causative agent of TB. Upon reaching the alveoli, the bacilli are engulfed by alveolar macrophages. However, due to their specialized lipid-rich cell wall, these pathogens...
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:

Articles linked to this work by shared authors, journal, and citation graph.

Immune dysregulation in tuberculosis-diabetes comorbidity: mechanistic and translational insights.

Frontiers in immunology·2026

Oxysterol signaling in the central nervous system: cellular mechanisms and implications for neurodegeneration.

Frontiers in molecular neuroscience·2026

Characterizing the tuberculosis and type 2 diabetes mellitus comorbidity in a South African cohort using untargeted GCxGC-TOFMS metabolomics.

Metabolomics : Official journal of the Metabolomic Society·2026

Human alveolar macrophage function is impaired in tuberculosis contacts with diabetes.

EBioMedicine·2025

Human alveolar macrophage response to Mycobacterium tuberculosis: immune characteristics underlying large inter-individual variability.

Communications biology·2025

HUMAN ALVEOLAR MACROPHAGE FUNCTION IS IMPAIRED IN TUBERCULOSIS CONTACTS WITH DIABETES.

Research square·2024

Differences in microbiota profiles of simple and complicated pediatric appendicitis cases.

Frontiers in cellular and infection microbiology·2026

Gut microbiota and serum metabolomics in children with human parainfluenza virus infection.

Frontiers in cellular and infection microbiology·2026

Comparative histopathological and immunohistochemical features of central nervous system and pulmonary tuberculosis: an exploratory retrospective study.

Frontiers in cellular and infection microbiology·2026

Moxibustion and the gut microbiota-inflammation axis: a systematic review and meta-analysis of clinical and preclinical studies.

Frontiers in cellular and infection microbiology·2026

Molecular epidemiology of carbapenemase-producing gram-negative bacilli in diabetic foot infections: association with glycemic control.

Frontiers in cellular and infection microbiology·2026

Beyond susceptibility testing: traditional Chinese medicine-associated compounds as candidate antibiotic adjuncts in chronic-wound biofilms.

Frontiers in cellular and infection microbiology·2026

Myroides bacteremia associated with wound myiasis: A case report and focused literature review.

IDCases·2026

CD300f acts as an inducible inhibitory checkpoint that limits mast cell activation by suppressing MITF-dependent activation.

The Journal of investigative dermatology·2026

Histomorphometric analysis of invasive fungal infections.

Journal de mycologie medicale·2026

Spinal subependymoma mimicking an intradural extramedullary tumor: illustrative case.

Journal of neurosurgery. Case lessons·2026

The Fleming Fund: Key Features of Design and Approach to Strengthening Antimicrobial Resistance Surveillance in Low- and Middle-Income Countries.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026

MARDy 2.0: a platform for exploring and analysing antifungal resistance mutations.

Bioinformatics (Oxford, England)·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us